Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens.

作者: L. Clifford McDonald , Shannon Rossiter , Constance Mackinson , Yong Yu Wang , Susan Johnson

DOI: 10.1056/NEJMOA010805

关键词:

摘要: Background The combination of the streptogramins quinupristin and dalfopristin was approved in United States late 1999 for treatment vancomycin-resistant Enterococcus faecium infections. Since 1974, another streptogramin, virginiamycin, has been used at subtherapeutic concentrations to promote growth farm animals, including chickens. Methods To determine frequency quinupristin-dalfopristin–resistant E. faecium, we selective medium culture samples from chickens purchased supermarkets Georgia, Maryland, Minnesota, Oregon stool outpatients. Results Between July 1998 June 1999, 407 26 stores four states were cultured, as 334 Quinupristin-dalfopristin–resistant isolated 237 chicken carcasses 3 specimens. resistant isolates had low-level resistance (minimal inhibitory concentration [MIC], 4 μg per milliliter; defined ...

参考文章(35)
M Ford, J D Perry, F K Gould, Use of cephalexin-aztreonam-arabinose agar for selective isolation of Enterococcus faecium. Journal of Clinical Microbiology. ,vol. 32, pp. 2999- 3001 ,(1994) , 10.1128/JCM.32.12.2999-3001.1994
P. Van der Auwera, N. Pensart, V. Korten, B. E. Murray, R. Leclercq, Influence of Oral Glycopeptides on the Fecal Flora of Human Volunteers: Selection of Highly Glycopeptide-Resistant Enterococci The Journal of Infectious Diseases. ,vol. 173, pp. 1129- 1136 ,(1996) , 10.1093/INFDIS/173.5.1129
MA Schouten, A Voss, JAA Hoogkamp-Korstanje, European VRE Study Group†, Antimicrobial Susceptibility Patterns of Enterococci Causing Infections in Europe Antimicrobial Agents and Chemotherapy. ,vol. 43, pp. 2542- 2546 ,(1999) , 10.1128/AAC.43.10.2542
I. Klare, H. Heier, H. Claus, R. Reissbrodt, W. Witte, vanA‐mediated high‐level glycopeptide resistance in Enterococcus faecium from animal husbandry Fems Microbiology Letters. ,vol. 125, pp. 165- 171 ,(1995) , 10.1111/J.1574-6968.1995.TB07353.X
Mehnam Soltani, David Beighton, John Philpott-Howard, Neil Woodford, Mechanisms of resistance to quinupristin-dalfopristin among isolates of Enterococcus faecium from animals, raw meat, and hospital patients in Western Europe. Antimicrobial Agents and Chemotherapy. ,vol. 44, pp. 433- 436 ,(2000) , 10.1128/AAC.44.2.433-436.2000
M S Whitman, P G Pitsakis, E DeJesus, A J Osborne, M E Levison, C C Johnson, Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model. Antimicrobial Agents and Chemotherapy. ,vol. 40, pp. 1526- 1530 ,(1996) , 10.1128/AAC.40.6.1526
H P Endtz, N van den Braak, A van Belkum, J A Kluytmans, J G Koeleman, L Spanjaard, A Voss, A J Weersink, C M Vandenbroucke-Grauls, A G Buiting, A van Duin, H A Verbrugh, Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands Journal of Clinical Microbiology. ,vol. 35, pp. 3026- 3031 ,(1997) , 10.1128/JCM.35.12.3026-3031.1997
R Rende-Fournier, R Leclercq, M Galimand, J Duval, P Courvalin, Identification of the satA gene encoding a streptogramin A acetyltransferase in Enterococcus faecium BM4145. Antimicrobial Agents and Chemotherapy. ,vol. 37, pp. 2119- 2125 ,(1993) , 10.1128/AAC.37.10.2119
Michael A. Pfaller, Marie L. Landry, Ellen Jo Baron, Patrick R. Murray, James H. Jorgensen, Manual of clinical microbiology ,(1974)